Director Borgeson Blake sold $105,600 worth of shares (30,000 units at $3.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,199,863 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RXRX· Recursion Pharmaceuticals Inc.

Health Care

Original source

Director Borgeson Blake sold $105,600 worth of shares (30,000 units at $3.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 6,199,863 units (SEC Form 4) | Quantisnow